International Biotechnology Ownership

IBT Stock   633.00  5.00  0.78%   
International Biotechnology Trust has a total of 35.39 Million outstanding shares. Roughly 71.23 (percent) of International Biotechnology outstanding shares are held by general public with 1.42 % owned by insiders and only 27.35 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2004-03-31
Previous Quarter
38.9 M
Current Value
36.8 M
Avarage Shares Outstanding
46.7 M
Quarterly Volatility
9.1 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in International Biotechnology Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

International Stock Ownership Analysis

About 27.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.8. Some equities with similar Price to Book (P/B) outperform the market in the long run. International Biotechnology last dividend was issued on the 19th of December 2024. To learn more about International Biotechnology Trust call the company at 44 20 7421 7070 or check out https://www.internationalbiotrust.com.

International Biotechnology Outstanding Bonds

International Biotechnology issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. International Biotechnology uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most International bonds can be classified according to their maturity, which is the date when International Biotechnology Trust has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in International Stock

International Biotechnology financial ratios help investors to determine whether International Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in International with respect to the benefits of owning International Biotechnology security.